Financial Data and Key Metrics Changes - Ambac reported a net loss from continuing operations of $21 million or $0.45 per share, compared to a loss of $15 million or $0.33 per share in the previous year, driven by increased intangible amortization and interest expense [13] - Total revenues from continuing operations increased by 8% to $55 million compared to the previous year [14] - Adjusted EBITDA from continuing operations was a loss of $5 million, compared to a loss of less than $1 million in the previous year [13][14] Business Line Data and Key Metrics Changes - The operating businesses generated $346 million in premium, up 110%, and $54 million in revenue, up 20% from the prior year [6] - The Insurance Distribution segment, Serato, generated $250 million in premium for the quarter, up 368% [7] - Everspan's net written and net earned premiums were $15 million and $16 million, down from $32 million and $27 million respectively, due to proactive non-renewal of certain programs [17] Market Data and Key Metrics Changes - Organic growth, including BEAT, was over 12% in the quarter, despite a slight pullback due to industry turbulence in the ESL and short-term medical markets [10] - The ESL markets are beginning to stabilize, showing early signs of improvement [10] - The loss ratio for Everspan improved to 67.8% from 85.1% in the previous year [17] Company Strategy and Development Direction - The company plans to launch several strategic initiatives post-sale of its legacy financial guaranty business, including organizational rebranding and a new executive compensation program [5][6] - Ambac aims to position itself as a growth platform with a target of $80 million to $90 million of adjusted EBITDA for common shareholders by 2028 [21] - Continued investment in data and AI technologies is part of the strategic initiatives to enhance growth and performance [10][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth of the Specialty P&C business and the anticipated closing of the legacy business sale [20] - The company expects to see strong performance in the third and fourth quarters, historically being the strongest periods [30] - Management remains focused on profitability while balancing growth, particularly in Everspan [25] Other Important Information - The company experienced net FX losses of $2.5 million, which were offset by net translation gains of $20 million [15] - The expense ratio for Everspan increased to 38.9% from 24.3% in the prior year, driven by various factors including lower earned premium [18] Q&A Session Summary Question: Anticipated impact of runoff in Everspan - Management expects around $400 million of gross premium for the year, focusing on profitability rather than pushing for growth [25] Question: Net growth expectations - Management indicated that net retention levels are expected to average between 15% to 20% going forward [26] Question: Commission income dynamics in distribution business - Seasonal issues and different reporting frameworks for BEAT's commissions were noted as factors affecting commission income [27] Question: Outlook for A&H and ESL markets - Management sees stabilization in the A&H space and expects the third and fourth quarters to be strong [30] Question: Performance in property markets - The company has seen some price pressures in large property markets but is primarily focused on non-cat exposed property, with mid-single-digit declines expected [32]

Second Quarter 2025 Highlights - P&C premium production increased by 110% to approximately $346 million[5] - P&C revenue increased by 21% to approximately $54 million, and total revenue increased by 8% to approximately $55 million[5] - Cirrata's premium placed increased 368% to $250 million[12] - Cirrata's total revenue increased 148% to $33 million year-over-year[12] Segment Performance - Everspan's Gross Written Premiums (GPW) was $96 million, down (13)% compared to the second quarter of 2024[15] - 61% of Everspan's 2Q25 GPW is E&S lines[15] - Cirrata experienced organic growth of (3)%[12] - Beat Capital had organic growth of approximately 26%, and Cirrata Proforma Organic Growth Inclusive of Beat was approximately 12%[5] Profitability Metrics - Cirrata reported a net loss of $(8) million with a margin of (24)%[12] - Cirrata's Adjusted EBITDA was $5 million with a margin of 14%[12] - Cirrata's Adjusted EBITDA to shareholders was $3 million with a margin of 8%[12]

Ambac Financial Group (AMBC) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +8.33%. A quarter ago, it was expected that this bond insurer would post a loss of $0.07 per share when it actually produced a loss of $0.13, delivering a surprise of -85.71%.Over the last four quarters, the comp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 1-10777 AMBAC FINANCIAL GROUP, INC. (Exact name of Registrant as specified in its charter) (State of incorporation) Delaware 13-3621676 (I.R.S. employer identification no.) One Wor ...

Exhibit 99.1 Ambac Reports Second Quarter 2025 Results • Insurance Distribution ("Cirrata") ◦ Total revenue grew to $33 million for the quarter, an increase of 148% ◦ Net loss to Shareholders of $(8) million for the quarter ◦ Adjusted EBITDA of $5 million for the quarter, up 91% ◦ Adjusted EBITDA to Shareholders of $3 million for the quarter, up 28% • Specialty P&C Insurance ("Everspan") ◦ Combined ratio of 107%, down by 270 bps ◦ Loss ratio of 67.8%, down 17 percentage points NEW YORK, NY, August 7, 2025 ( ...

Group 1 - Ambac Financial Group (AMBC) shares increased by 17.7% to close at $8.65, with trading volume significantly higher than usual [1] - The surge in Ambac shares is attributed to a scheduled hearing by the Wisconsin Office of the Commissioner of Insurance regarding the sale of Ambac Assurance Corporation, marking a key step in regulatory approval [2] - Ambac is expected to report a quarterly loss of $0.24 per share, a year-over-year decline of 233.3%, with revenues projected at $55.59 million, down 47.1% from the previous year [3] Group 2 - The consensus EPS estimate for Ambac has been revised 25% higher in the last 30 days, indicating a potential for price appreciation [4] - Ambac currently holds a Zacks Rank of 3 (Hold) within the Insurance - Property and Casualty industry [5] - RLI Corp., a peer in the same industry, has seen a consensus EPS estimate decrease of 0.4% over the past month, reflecting a 12.8% decline from the previous year [6]

Group 1 - Ambac Financial Group, Inc. (NYSE: AMBC) is expected to receive $420 million from Oaktree Capital soon [1] - The company is engaged in ongoing discussions to acquire one or more businesses, which may attract new investors [1] - The independent investor emphasizes the importance of cash flow statements and unlevered free cash flow figures in evaluating companies [1] Group 2 - The investor typically focuses on established companies rather than growth stocks, analyzing financial metrics such as EV/FCF, net income, and EV/EBITDA [1] - The investor aims to contribute to the investment community by sharing insights and learning from others [1]

Quarterly Highlights Forward Looking Statement In this presentation, we have included statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "estimate," "project," "plan," "believe," "anticipate," "intend," "planned," "potential" and similar expressions, or future or conditional verbs such as "will," "should," "would," "could," and "may," or the negative of those expressions or verbs, ...

Financial Data and Key Metrics Changes - Ambac generated $318 million in premium, up 70%, and $63 million in revenue, up 27% from the prior year [6][12] - The net loss from continuing operations was $16 million or $0.58 per share, compared to a loss of $4 million or $0.09 per share in the same quarter last year [12] - Adjusted EBITDA from continuing operations was a loss of $1 million compared to a slight profit in the first quarter of 2024 [13] Business Line Data and Key Metrics Changes - The distribution business segment, Serata, generated over $230 million in premium for the quarter, up 156% [6] - Everspan's gross premiums written were approximately $87 million, down 10% from the prior year [10] - Dorado revenue increased by 129% to $41 million, driven primarily by the acquisition of B Capital [14] Market Data and Key Metrics Changes - Organic growth, excluding the Beat acquisition, contracted by 2%, but would have been almost 12% without the pullback in ESL and short-term medical business [7] - Everspan's loss ratio improved to 66.9% from 75.7% in the prior year [15] - The combined ratio for Everspan was 102.1%, up from 98.4% last year [16] Company Strategy and Development Direction - The company aims to maintain profitable underwriting results and expand its specialty P&C business, focusing on organic and inorganic growth [8][17] - Ambac plans to generate $80 million to $90 million of adjusted EBITDA for common shareholders by 2028 [18] - The company is enhancing risk capacity, product expansion, and distribution to drive synergies across its platform [9] Management's Comments on Operating Environment and Future Outlook - Management believes market conditions are stabilizing and turning favorable for growth despite challenges in ESL [8] - The company is focused on building a long-term business model that resonates in the specialty MGA and delegated authority program space [17] - Management sees significant opportunities for staffing growth and attracting top talent in the current market [20] Other Important Information - The OCI approval process for the sale of the legacy business is ongoing, which is expected to transform Ambac into a pure play specialty P&C insurance business [11] - The increase in total expenses was driven by a $21 million increase in general and administrative expenses related to the acquisition of Beat [13] Q&A Session Summary Question: Importance of staffing to top line growth and market conditions for recruiting - Management emphasized that staffing is crucial for individual MGAs and that there are significant opportunities for staffing growth due to the attractiveness of their business model [20][21] Question: Update on property versus casualty mix and growth outlook - Management indicated that liability will be the primary source of growth, while property remains attractive despite softening prices [22][23] Question: Comments on the competitive environment - Management acknowledged growing competition but believes their unique business model and capacity relationships allow them to attract top talent [25]

Financial Data and Key Metrics Changes - Ambac generated a net loss from continuing operations of $16 million or $0.58 per share in Q1 2025, compared to a loss of $4 million or $0.09 per share in Q1 2024 [10] - Total revenues from continuing operations increased by 27% to $63 million in Q1 2025, driven primarily by the acquisition of Beat [11] - Adjusted EBITDA from continuing operations was a loss of $1 million, compared to a slight profit in Q1 2024 [11] Business Line Data and Key Metrics Changes - The insurance distribution and specialty program business produced $318 million of premium, up 70%, and generated $63 million of revenue, up 27% from the prior period last year [5] - Serata generated over $230 million of premium for the quarter, up 156% [5] - Everspan's gross premiums written were approximately $87 million, down 10% from the prior year, while the loss ratio improved nearly 9% [8] Market Data and Key Metrics Changes - Organic growth, excluding the Beat acquisition, contracted by 2%, primarily due to a pullback in ESL and short-term medical business [6] - If FEED had been included in the organic growth computation, consolidated organic growth would have been approximately 17% across all lines [6] Company Strategy and Development Direction - The company aims to maintain profitable underwriting results and believes market conditions are stabilizing for growth [7] - Focus areas for enhancing organic growth include risk capacity enhancement, product expansion, and distribution expansion [7] - The company is building its business for the long term, targeting $80 million to $90 million of adjusted EBITDA for common shareholders by 2028 [16][17] Management's Comments on Operating Environment and Future Outlook - Management noted that the competitive environment is growing, but the company's unique business model allows it to attract top talent [24] - The company sees significant opportunities in the specialty P&C business and is focused on scaling its platform [16] Other Important Information - The OCI approval process for the sale of the legacy business is ongoing, which is expected to transform the company into a pure play specialty P&C insurance business [9] Q&A Session Summary Question: Importance of staffing for MGA ramp-up and market conditions for recruiting - Management emphasized that staffing is crucial for individual MGAs and that there are significant opportunities for staffing growth due to the attractiveness of the business model [19][20] Question: Update on property versus casualty mix and growth outlook - Management indicated that liability business will be the primary source of growth, while property remains critical, with a focus on diversifying the property segments [21][23] Question: Comments on the competitive environment - Management acknowledged growing competition but believes their differentiated model allows them to attract top talent and maintain a competitive edge [24]